CompletedNCT02044809
Cannabidiol: a Novel Intervention for Cannabis Use Problems?
Medication studyAges 16–60United KingdomAddiction
Understand this study
Who was this study for?
Listed age limits: 16 years to 60 years.
- Listed locations
- LondonSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Study information
Study start dateMarch 2014
- Recruitment status
- Completed
- Enrollment listed in the registry
- 82
- Sponsor
- University College, London
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- United Kingdom
- Age range
- From 16 Years to 60 Years
- Official registry ID
- NCT02044809
- Official title
Show the full official title
A Phase IIa/b, Randomised, Double-blind, Placebo-controlled, Single-site, Parallel Group Clinical Trial to Examine Cannabidiol (CBD) as a Pharmacological Treatment for Cannabis Dependence.
Get this study by email
Recruitment & locations
CompletedLondon
Questions about this study
Who is behind this study?
The study sponsor is University College, London, a university.
Did this study involve medication?
Yes. The study involved medication, including Cannabidiol and Placebo.
Who was this study for?
Listed age limits: 16 years to 60 years.
Want to explore more studies?
Explore studiesRelated studies
A phase II, randomised, double-blind, placebo- controlled, multi-site, parallel group clinical trial to examine ketamine as a pharmacological treatment for alcohol dependence in an alcohol dependen...
A Study of Oral Ibogaine in Opioid Withdrawal